Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115043846B details a visible-light catalyzed route for pyrroloindole derivatives, offering scalable manufacturing and cost-effective pharmaceutical intermediate production.
Patent CN113292633B enables catalyst-free visible light hydrazine modification. Offers high purity unnatural amino acids with reduced manufacturing costs and scalable supply chain reliability.
Patent CN116574072A details a green visible-light method for 2,5-diaryl furans. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Ir-catalyzed visible light method for polysubstituted cyclopropanes. Enhances yield, reduces by-products, ensures scalable API intermediate production.
Patent CN114835660A reveals a metal-free, visible-light mediated method for oxime ether synthesis, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114773284B details a visible light-mediated synthesis of dihydroisoxazoles using terminal olefins. Offers mild conditions and cost-effective raw materials for pharmaceutical intermediates.
Patent CN110759836B reveals a metal-free fluoroalkylation method using acetone and visible light, offering cost-effective synthesis for high-purity pharmaceutical intermediates.
Patent CN113461617A reveals a metal-free visible light method for N-heterocycles. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN110981676A discloses a metal-free visible light method for beta-ketosulfones. Offers cost reduction and green manufacturing for pharmaceutical intermediates.
Novel metal-free decarboxylative ketonization method offers cost-effective, scalable production of high-purity pharmaceutical intermediates with green chemistry advantages.
Patent CN112390755B enables mild heteroarylation of amines using visible light. This breakthrough offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Novel carboxyl-substituted ruthenium complex enables efficient photocatalytic dye degradation, offering a sustainable solution for industrial wastewater purification.
Patent CN116713034B reveals organic photocatalyst for KIP. High yield, mild conditions, cost reduction in vitamin E intermediate manufacturing.
Patent CN105130898A enables visible-light synthesis of gem-difluoro polycyclic compounds. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN108727246B details a metal-free visible light method for indole C3 alkylation using organic dyes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN120098034A reveals a neutral photocatalytic route for 1,2-bisphosphonoethane compounds, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN118125897A reveals a room-temperature visible-light method for Z-selective monofluoroolefin synthesis, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN108623494B details a green photocatalytic method for synthesizing imines using sulfur-containing aza metalloporphyrin, offering high selectivity and cost reduction.
Patent CN105985290B reveals oxidant-free visible light photocatalysis for isoquinoline derivatives. This method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN113121338A reveals a green photocatalytic method for alpha-hydroxylation using air and visible light, offering significant cost reduction in pharmaceutical intermediate manufacturing.